Emerging Resistance among Uropathogens: Is Fosfomycin Revival the Best Hope?
Introduction: Increasing bacterial resistance and the nonavailability of newer antimicrobial agents have necessitated the re-evaluation of old antimicrobial agents. Although an old antibiotic, Fosfomycin gives a ray of hope as it has a unique property of not sharing structural similarity with oth...
Príomhchruthaitheoirí: | Sonali Bhattar, Priyanjali Shingare, Richa Anjleen Tigga, Shariqa Qureshi, Vikas Sharma |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
JCDR Research and Publications Private Limited
2020-07-01
|
Sraith: | Journal of Clinical and Diagnostic Research |
Ábhair: | |
Rochtain ar líne: | https://jcdr.net/articles/PDF/13838/44367_CE[Ra1]_F(SL)_PF1(AG_KM)_PFA(KM)_PB(AG_KM)_PN(SL).pdf |
Míreanna comhchosúla
Míreanna comhchosúla
-
Nitrofurantoin Revisited for Uropathogens: Easing out Therapeutic Dilemma for Clinicians in an Upcoming Super Speciality Hospital
de réir: Sonali Bhattar, et al.
Foilsithe / Cruthaithe: (2020-04-01) -
Fosfomycin: A Substitute in Therapeutic Options for Extended Spectrum Beta-lactamase Producing Uropathogens
de réir: Faiza Zeeshan et al, et al.
Foilsithe / Cruthaithe: (2024-05-01) -
Increasing antimicrobial resistance among uropathogens: Is fosfomycin the answer?
de réir: Asfia Sultan, et al.
Foilsithe / Cruthaithe: (2015-01-01) -
ß-Lactam-ß-lactamase Inhibitor Combination against ESBL-Producing Enterobacteriaceae
de réir: A Hashemi
Foilsithe / Cruthaithe: (2016-05-01) -
Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017
de réir: Vikas Gupta, et al.
Foilsithe / Cruthaithe: (2019-08-01)